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Influence of Donor-Recipient Strain Combinations on Immunologic 
Responses after Allogeneic Rat Small Bowel Transplantation 
M. Tanabe, N. Murase, A.J. Demetris, A.A. Hoffman, K. Nakamura, S. Fujisaki, F.H.F. Galvao, S. Todo, 
and T. E. Starzl 
GENETIC FACTORS are known to control alloreac-tivity and can affect the outcome after orthotopic 
small bowel transplantation (SBTx). The present study 
was undertaken to determine the effect of donor and 
recipient strains on long-term graft viability and the inci-
dence of graft versus host disease (aVHD) after rat SBTx. 
MATERIALS AND METHODS 
Operation and Experimental Design 
Orthotopic SBTx with ponocaval drainage l was perfonned with 
or without immunosuppression in 12 fully allogeneic rat strain 
combinations between LEW (RTI). BN (RT"). pva (RTle ). and 
ACI (RTla) rats (purchased from Harlan Sprague-Dawley Inc. 
Indianapolis. IN). For immunosuppression. FK 506 dissolved in 
HCO-60 and D-mannitol carrier solvent (gift from Fujisawa Pharm 
Co Ltd. Osaka. Japan) was given intramuscularly (0.64 mglkgld on 
days 0 to 13). 
Immunologic Testing of Long-Term Survivors after SBTx 
Animals surviving> 150 days without signs of rejection were 
funher evaluated for their immunologic status by skin grafting, 
mixed lymphocyte reaction (MLR). and cell-mediated lympho-
lysis (CML). Recipient chimerism was also studied by immuno-
histochemistry . 
RESULTS 
Animal Survival after SBTx 
In all 12 combinations. untreated recipients died of rejec-
tion with median survivals of 5 to 14 days. There were no 
statistically significant differences in survival when the 
results were examined from the perspective of either the 
donor or the recipient strain. 
Treatment with FK 506 significantly prolonged overall 
survival (P < .0)): however. the degree of prolongation 
and incidence of aVHD was dependent on the recipient 
strain. Survival of BN recipients was less than that of any 
other recipients regardless of the donor strain. However. 
within the BN group. the specific cause for the poor 
outcome differed. BN recipients of ACI grafts died of 
rejection with a median survival of91 days. When PVG or 
LEW donors were used. the BN recipients invariably 
succumbeded to G VHD between 32 and 42 days. No other 
recipients had any signs of GVHD when treated with FK 
506. Survival of the LEW recipients showed some depen-
dence on the donor strain. ACI grafts were most promptly 
rejected. with a median survival of 133 days. Although 
most of the LEW recipients of BN (61'10) or PVG (3/4) 
grafts survived for more than 150 days. 70% of the BN 
grafts and 50t;f of the PVG grafts in LEW recipients were 
associated with diarrhea and more than 10% body weight 
loss. In contrast. all PVG and ACI recipients survived for 
> ISO days with a steady weight gain. except for three rats 
that died early because of obstructive ileus. 
Pathologic Observations (HE Staining) 
Results of the examination of specimens from treated 
animals were congruent with the clinical impression in 
different strain combinations. The skin of BN recipients of 
LEW or pva bowel grafts showed changes typical of 
acute aVHD. 2 The bowel graft was normal in these 
animals. In contrast. findings of the ACI grafts in BN 
recipients and all strain grafts in LEW recipients are 
diagnostic of chronic rejection.) Although both ACI and 
PVG recipients appeared healthy after SBTx. the grafts in 
pva recipients showed minimal chlinges of chronic rejec-
tion. whereas ACI recipients appeared to be completely 
spared from rejection. Because signs of rejection were 
minimal to rare in treated ACI and PVG recipients, they 
were further evaluated for their immunologic status. 
Immunologic Testing of Long-Term Survivors after SeTx 
Skin Graft Challenge. Long-surviving pva and ACI 
recipients of bowel grafts rejected third-pany skin graft in 
the same tempo as naive animals (median = 10.5 and to 
days. respectively). In contrast. the survival of skin grafts 
from the bowel donor strain was more than double in pva 
recipients (median = 23.5 days) and indefinite (median> 
100 days) in ACI recipients. 
MLR. Long-surviving pva recipients normally re-
sponded to bowel donor and third-party stimulators. In 
contrast. all long-surviving ACI recipients had reduced 
reactivity to donor strain stimulators but responded nor-
mally to third-pany stimulators. 
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CML. The CML responses oflong-surviving ACI recip-
ients to donor strain and third-party targets were essen-
tially identical to naive ACI responses. 
Assessment for Microchimerism. Immunopathologic 
study of lymphoid tissues obtained from long-surviving 
ACI recipients of PVG grafts revealed some OX27+ cells 
(PYG donor origin). However. the presence of ACI donor 
cells (MN4-91-6+) was less obvious in the long-surviving 
PYG recipients of ACI grafts. 
DISCUSSION 
Our results show that a short course of immunosuppres-
sion unmasks strong recipient effects on the outcome of 
isolated small bowel transplantation. Both ACI and PYG 
recipients demonstrated consistent long-term survival, 
whereas LEW recipients showed substantial chronic re-
jection regardless of donor strain. On the other hand. BN 
recipients were relatively unique in experiencing fatal 
GYHD with PYG or LEW grafts. whereas they aggres-
sively rejected ACI grafts. The unique susceptibility of BN 
recipients to GYRD might have some relationship to the 
relative ease with which autoimmune disease was induced 
by injecting heavy metals to this strain.4 
TANABE. MURASE. OEMETRIS ET AL 
Immunohistochemical staining showed that the ACI 
recipients. which were tolerant of subsequent donor skin 
grafts. were microchimerics. Persistence of donor cells in 
the recipients has been thought to be a key for graft 
acceptance. S Although a correlation was noted between 
the clinical and pathologic condition of the bowel grafts 
and subsequent skin graft acceptance. the same concor-
dance was not reflected in the in vitro immunologic testing. 
Perhaps isolation of the recipient cells from naturally 
occuring microenvironmental factors and network reac-
tions. which have been altered by transplantation. is 
responsible for this enigma. 
REFERENCES 
1. Murase N. Demetris AJ. Kim DG. et a1: Surgery 108:880. 
1990 
2. Murase N. Demetris AJ. Woo J. et al: Transplantation 55: 1. 
1993 
3. Murase N. Demetris AJ. Matsuzaki T. et al: Surgery 110:87. 
1991 
4. Aten J. Bosman CB. Rozing J. et al: Am J PathoI86:159. 
1986 
5. Starzi TE. Demetris AJ. Trueco M. et al: Hepatology 
17:1127. 1983 
